To determine the prevalence and genotype of an extended-spectrum beta-lactamase and new chromosomal AmpC beta-lactamases among clinical isolates of Enterobacter species, we performed antibiotic susceptibility testing, pI determination, induction tests, transconjugation, enterobacterial repetitive consensus (ERIC) PCR, sequencing, and phylogenetic analysis. Among the 51 clinical isolates collected from a university hospital in Korea, 6 isolates have been shown to produce SHV-12 and inducible AmpC beta-lactamases. These also included three isolates producing TEM-1b and one strain carrying TEM-1b and CMY-type beta-lactamases with a pI of 8.0. The results from ERIC PCR revealed that six isolates were genetically unrelated, suggesting that dissemination of SHV-12 was responsible for the spread of resistance to extended-spectrum beta-lactams in Korea. Six genes of inducible AmpC beta-lactamases that are responsible for the resistance to cephamycins (cefoxitin and cefotetan), amoxicillin, cephalothin, and amoxicillin-clavulanic acid were cloned and characterized. A 1,165-bp DNA fragment containing the ampC genes was sequenced and found to have an open reading frame coding for a 381-amino-acid beta-lactamase. The nucleotide sequence of four ampC genes (bla EcloK992004.1 , bla EcloK995120.1 , bla EcloK99230 , and bla EareK9911729 ) shared considerable homology with that of AmpC-type class C beta-lactamase genes of gram-negative bacteria, especially that of the chromosomal ampC gene (bla EcloMHN1 ) of Enterobacter cloacae MHN1 (99.9, 99.7, 99.6, and 99.6% identity, respectively). The sequences of two ampC genes (bla EcloK9973 and bla EcloK9914325 ) showed close similarity to the chromosomal ampC gene (bla EcloQ908R ) of E. cloacae Q908R (99.7% identity). The results from phylogenetic analysis suggested that six ampC genes could originate from bla EcloMHN1 or bla EcloQ908R .The beta-lactamases (EC 3.5.2.6) produced by the bacterium have been known to protect against the lethal effect of penicillins, cephalosporins, or monobactams on cell-wall synthesis. A variety of beta-lactamases have been classified into classes A, B, C, and D according to their amino acid homologies (4). AmpC beta-lactamases, mostly conferring resistance to many beta-lactam antibiotics (cephamycins and broad-spectrum cephalosporins), are included in class C beta-lactamases. Chromosomally encoded AmpC beta-lactamases are present in Enterobacter spp., Shigella spp., Serratia marcescens, Citrobacter freundii, Morganella morganii, Providencia spp., Pseudomonas aeruginosa, and Escherichia coli (16). Enterobacter species are becoming increasingly important as nosocomial pathogens (22). Risk factors for nosocomial Enterobacter infection include the prior use of antimicrobial agents, a prolonged hospital stay, a serious underlying illness, immunosuppression, and the presence of a foreign device (2). In view of the spreading risk of AmpC resistance determinants among enterobacterial isolates, it is necessary to elucidate the AmpC resistance mechanism. The prese...